share_log

HC Wainwright & Co. Reiterates Buy on Medicenna Therapeutics, Maintains $2.5 Price Target

HC Wainwright & Co. Reiterates Buy on Medicenna Therapeutics, Maintains $2.5 Price Target

HC Wainwright & Co.重申买入Medicenna Therapeutics,维持2.5美元的目标股价
Benzinga ·  2023/08/10 03:46

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Medicenna Therapeutics (NASDAQ:MDNA) with a Buy and maintains $2.5 price target.

HC Wainwright&Co.分析师Swayampakula Ramakanth重申美第奇拿治疗公司(纳斯达克:mDNA)的买入,并维持2.5美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发